skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience
Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience
Material Type:
Artigo 		Adicionar ao Meu Espaço

Stroke in Patients With Type 2 Diabetes Mellitus, Chronic Kidney Disease, and Anemia Treated With Darbepoetin Alfa The Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT) Experience

Hicham Skali Hans-Henrik Parving; Patrick S Parfrey; Emmanuel A Burdmann; Eldrin F Lewis; Peter Ivanovich; Sai Ram Keithi-Reddy; Janet B McGill; John J. V McMurray; Ajay K Singh; Scott D Solomon; Hajime Uno; Marc A Pfeffer

Circulation Baltimore v. 124, n. 25, p. 2903-2908, 2011

Baltimore 2011

Acesso online. A biblioteca também possui exemplares impressos.

2
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR) a double-blind, randomised, placebo-controlled trial
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR) a double-blind, randomised, placebo-controlled trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR) a double-blind, randomised, placebo-controlled trial

Hiddo J. L Heerspink Hans-Henrik Parving; Dennis L Andress; George Bakris; Ricardo Correa-Rotter; Fan-Fan Hou; Dalane W Kitzman; Donald Kohan; Hirofumi Makino; Emmanuel de Almeida Burdmann

Lancet v. 393, n. 10184, p. 1937-1947, 2019

New York 2019

Acesso online. A biblioteca também possui exemplares impressos.

3
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease
Material Type:
Artigo 		Adicionar ao Meu Espaço

Metformin use and cardiovascular events in patients with type 2 diabetes and chronic kidney disease

David M Charytan Scott D Solomon; Peter Ivanovich; Giuseppe Remuzzi; Mark E Cooper; Janet B Mcgill; Hans-Henrik Parving; Patrick Parfrey; Ajay K Singh; Emmanuel de Almeida Burdmann

Diabetes obesity & metabolism v. 21, n. 5, p. 1199-1208, 2019

Hoboken 2019

Acesso online. A biblioteca também possui exemplares impressos.

4
Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective
Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prevalence and risk factors for microalbuminuria in a referred cohort of type II diabetic patients: A global perspective

Parving, H.-H. ; Lewis, J.B. ; Ravid, M. ; Remuzzi, G. ; Hunsicker, L.G.

Kidney international, 2006-06, Vol.69 (11), p.2057-2063 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
5
Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes
Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes
Material Type:
Artigo 		Adicionar ao Meu Espaço

Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes

Schievink, B. ; Kröpelin, T. ; Mulder, S. ; Parving, H.-H. ; Remuzzi, G. ; Dwyer, J. ; Vemer, P. ; de Zeeuw, D. ; Lambers Heerspink, H. J.

Diabetes, obesity & metabolism, 2016-01, Vol.18 (1), p.64-71

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
6
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial
Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Is a reduction in albuminuria associated with renal and cardiovascular protection? A post hoc analysis of the ALTITUDE trial

Heerspink, H. J. L. ; Ninomiya, T. ; Persson, F. ; Brenner, B. M. ; Brunel, P. ; Chaturvedi, N. ; Desai, A. S. ; Haffner, S. M. ; Mcmurray, J. J. V. ; Solomon, S. D. ; Pfeffer, M. A. ; Parving, H.-H. ; de Zeeuw, D.

Diabetes, obesity & metabolism, 2016-02, Vol.18 (2), p.169-177

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
7
Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study
Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Plasma matrix metalloproteinases are associated with incident cardiovascular disease and all-cause mortality in patients with type 1 diabetes: a 12-year follow-up study

Peeters, S A ; Engelen, L ; Buijs, J ; Jorsal, A ; Parving, H-H ; Tarnow, L ; Rossing, P ; Schalkwijk, C G ; Stehouwer, C D A

Cardiovascular diabetology, 2017-04, Vol.16 (1), p.55-55, Article 55 [Periódico revisado por pares]

England: BioMed Central

Texto completo disponível

Citações Citado por
8
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril
Material Type:
Artigo 		Adicionar ao Meu Espaço

Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril

Nielsen, S. E. ; Schjoedt, K. J. ; Astrup, A. S. ; Tarnow, L. ; Lajer, M. ; Hansen, P. R. ; Parving, H.-H. ; Rossing, P.

Diabetic medicine, 2010-10, Vol.27 (10), p.1144-1150 [Periódico revisado por pares]

Oxford, UK: Blackwell Publishing Ltd

Texto completo disponível

Citações Citado por
9
Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications
Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications
Material Type:
Artigo 		Adicionar ao Meu Espaço

Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications

FRYSTYK, J ; TAMOW, L ; HANSEN, T. Krarup ; PARVING, H.-H ; FLYVBJERG, A

Diabetologia, 2005-09, Vol.48 (9), p.1911-1918 [Periódico revisado por pares]

Berlin: Springer

Texto completo disponível

Citações Citado por
10
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study
Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Irbesartan treatment does not influence plasma levels of the dicarbonyls methylglyoxal, glyoxal and 3‐deoxyglucosone in participants with type 2 diabetes and microalbuminuria: An IRMA2 sub‐study

Piazza, M. ; Hanssen, N. M. J. ; Persson, F. ; Scheijen, J. L. ; Waarenburg, M. P. H. ; Greevenbroek, M. M. J. ; Rossing, P. ; Hovind, P. ; Stehouwer, C. D. A. ; Parving, H‐H. ; Schalkwijk, C. G.

Diabetic medicine, 2021-09, Vol.38 (9), p.e14405-n/a [Periódico revisado por pares]

England: Wiley Subscription Services, Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Refinar Meus Resultados

Tipo de Recurso 

  1. Artigos  (518)
  2. Anais de Congresso  (3)
  3. Conjunto de Dados  (1)
  4. Mais opções open sub menu

Data de Publicação 

De até
Refinar
  1. Antes de1982  (30)
  2. 1982Até1990  (70)
  3. 1991Até1999  (139)
  4. 2000Até2009  (198)
  5. Após 2009  (86)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (518)
  2. Japonês  (76)
  3. Dinamarquês  (3)
  4. Alemão  (1)
  5. Mais opções open sub menu

Novas Pesquisas Sugeridas

Ignorar minha busca e procurar por tudo

Deste Autor:

  1. Burdmann, E
  2. Parving, H
  3. McGill, J
  4. Singh, A
  5. Solomon, S

Neste Assunto:

  1. Humans
  2. Science & Technology
  3. Life Sciences & Biomedicine
  4. Male
  5. Female

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.